XML 43 R31.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Other Balance Sheet Components (Tables)
 6 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Accounts, Notes, Loans and Financing Receivable
Accounts receivable, net, as of June 30, 2024 and December 31, 2023 consisted of the following (in millions):
June 30,December 31,
20242023
Accounts receivable$492 $1,584 
Less: Wholesalers chargebacks, discounts and fees
(329)(692)
Accounts receivable, net$163 $892 
Schedule of Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets, as of June 30, 2024 and December 31, 2023 consisted of the following (in millions):
June 30,December 31,
20242023
Prepaid services$184 $182 
Down payments and prepayments related to manufacturing and materials
111 168 
Income tax receivable105 19 
Collaboration receivable73 61 
Interest receivable56 59 
Value added tax receivable26 50 
Prepaid income tax
25 — 
Other current assets31 88 
Prepaid expenses and other current assets$611 $627 
Schedule of Other Non-Current Assets
Other non-current assets, as of June 30, 2024 and December 31, 2023 consisted of the following (in millions):
June 30,December 31,
20242023
Down payments and prepayments, non-current
$321 $342 
Inventory, non-current(1)
161 170 
Goodwill
52 52 
Finite-lived intangible asset
42 44 
Equity investments31 66 
Other34 11 
Other non-current assets$641 $685 
_______
(1)Consisted of raw materials with an anticipated consumption beyond one year.
Schedule of Accrued Liabilities
Accrued liabilities, as of June 30, 2024 and December 31, 2023 consisted of the following (in millions):
June 30,December 31,
20242023
Provisions related to product sales (Note 3)
$554 $556 
Compensation-related187 245 
Manufacturing119 167 
Other external goods and services109 137 
Clinical trials96 175 
Property, plant and equipment93 94 
Development operations90 140 
Raw materials42 27 
Commercial
32 56 
Royalties10 122 
Loss on future firm purchase commitments(1)
1 79 
Accrued liabilities$1,333 $1,798 
______
(1)Related to losses that are expected to arise from firm, non-cancellable, commitments for future raw material purchases (Note 7).
Schedule of Other Current Liabilities
Other current liabilities, as of June 30, 2024 and December 31, 2023 consisted of the following (in millions):
June 30,December 31,
20242023
Lease liabilities - operating (Note 10)
$25 $25 
Other17 41 
Other current liabilities$42 $66 
Schedule of Deferred Revenue
The following table summarizes the activities related to product sales provision recorded as accrued liabilities for the six months ended June 30, 2024 (in millions):
Returns and other fees
Balance at December 31, 2023$(556)
Provision related to sales made in 2024
(62)
Payments and returns related to sales made in current period 13 
Payments and returns related to sales made in prior year
51 
Balance at June 30, 2024$(554)
The following table summarizes the activities in deferred revenue for the six months ended June 30, 2024 (in millions):
December 31, 2023AdditionsDeductionsJune 30, 2024
Product sales$613 $196 $(69)$740 
Grant revenue4 — — 4 
Collaboration revenue34 6 (7)33 
Licensing and royalty revenue
— 20 — 20 
Total deferred revenue$651 $222 $(76)$797